New Coagulation Analyzer Designed for Low-Volume Routine Testing

A new stand-alone, dedicated coagulation system suitable for low-volume routine testing (up to 120 samples per day) is now available.

The medical equipment manufacturer Roche (Basel, Switzerland) recently announced that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting the CE Marking for diagnostic tools.


The cobas t 411 analyzer was designed for use by low-volume central coagulation laboratories. Among its many innovative features, the instrument offers cap-piercing, which maximizes throughput when combined with five position rack-based sample handling. High on-board capacities for reagents and samples, along with continuous loading of reagents, samples, and consumables result in increased walk-away times. Efficient reagent use is optimized with on-board barcode scanning capability and cooled, tilted reagent racks. Patient safety is prioritized through the unique opto-mechanical detection principle by checking each sample before measurement, as well as the always available STAT port, whereby emergency samples can be immediately processed with test results returned in a timely fashion.

“We are entering into a new era of coagulation testing for Roche, through expansion of our coagulation solution and we will continue to develop systems which support our customer’s lab efficiency and productivity needs” said Jean-Claude Gottraux, head of professional diagnostics at Roche. “The cobas t 411 is the next foundation stone for Roche to become a total solution provider for coagulation testing in both the laboratory and at the point-of-care.”

Related Links:
Roche